CompletedNCT07346924
Effect of Probiotics on Relapsing-Remitting Multiple Sclerosis
Placebo comparisonAges 20–60EgyptDepression
Understand this study
Who was this study for?
Listed age limits: 20 years to 60 years.
- Listed locations
- CairoSee all locations and recruitment
Study information
Study start dateStarted: January 1, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 60
- Sponsor
- Cairo University
- Sponsor type
- University
- Study type
- Other
- Intervention type
- DIETARY_SUPPLEMENT, OTHER
- Study phase
- Not clearly listed
- Locations
- Egypt
- Age range
- From 20 Years to 60 Years
- Official registry ID
- NCT07346924
- Official title
Show the full official title
Probiotics as a Promising Adjunct: Improving Fatigue, Quality of Life, Disability, Mood and Inflammatory Markers in Egyptian Relapsing-Remitting Multiple Sclerosis
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cairo
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Cairo University, a university.
Who was this study for?
Listed age limits: 20 years to 60 years.
